3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lymphoma, Large B-Cell, Diffuse
6
Lymphoma, Non-Hodgkin
5
Lymphoma, Mantle-Cell
5
Hodgkin Disease
5
Lymphoma
4
Recurrence
3
Lymphoma, T-Cell
3
Lymphoma, Follicular
3
Uveal Melanoma
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Glioblastoma
2
Burkitt Lymphoma
2
Vasculitis, Central Nervous System
1
Stiff-Person Syndrome
1
Rasmussen subacute encephalitis
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
1
Plasmablastic Lymphoma
1
Pediatric Brain Tumor
1
Pancreatic Neoplasms
1
Opsoclonus-Myoclonus Syndrome
1
Oligodendroglioma
1
Neuromyelitis Optica
1
Neoplasms
1
Neoplasm Metastasis
1
Myasthenia Gravis
1
Melanoma
1
Lymphoma, T-Cell, Peripheral
1
Lymphoma, T-Cell, Cutaneous
1
Lymphoma, Large-Cell, Immunoblastic
1
Interventions
Cyclophosphamide
29
fludarabine phosphate
22
Whole-Body Irradiation
20
Mycophenolic Acid
20
fludarabine
19
asciminib
19
nilotinib
15
Tacrolimus
13
Imatinib Mesylate
12
Melphalan
11
Dasatinib
9
Sirolimus
8
Peripheral Blood Stem Cell Transplantation
8
Thiotepa
7
Granulocyte Colony-Stimulating Factor
7
Busulfan
7
Mesna
6
Cyclosporine
6
ponatinib
5
bosutinib
5
Stem Cell Transplantation
5
Filgrastim
5
venetoclax
4
ruxolitinib
4
blinatumomab
4
Specimen Handling
4
Cyclosporins
4
thymoglobulin
3
Bone Marrow Transplantation
3
Antilymphocyte Serum
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
×
Carmustine
×
1 year
×
Clear all
No trials found.